26
03
2025

PAGES

26
03
2025

spot_img

PAGES

Home Tekedia Forum

Tekedia Forum

Forum Navigation
Please or Register to create posts and topics.

US Funding Cuts Threaten Global HIV Fight: 2,000 New Infections Daily & Millions of Lives at Risk

US Funding Cuts Threaten Global HIV Progress, UNAids Chief Warns

The global fight against HIV is facing a catastrophic setback as the United States’ decision to pause foreign aid threatens to undo decades of progress. According to UNAids Executive Director Winnie Byanyima, the funding cuts could result in an additional 2,000 new HIV infections daily and over six million deaths over the next four years. This alarming projection comes as global HIV-related deaths have declined significantly from over two million in 2004 to 600,000 in 2023.

The Impact of US Foreign Aid Suspension

On his first day in office in January, President Donald Trump announced a 90-day suspension of foreign aid as part of a broader review of government spending. The result has been the termination of numerous programs under the US Agency for International Development (USAID), including those dedicated to HIV treatment and prevention. Many US-financed programs have received stop-work orders, leading to the closure of critical mother-and-baby clinics across Africa and severe shortages of life-saving antiretroviral (ARV) medicines.

Register for Tekedia Mini-MBA edition 17 (June 9 – Sept 6, 2025) today for early bird discounts. Do annual for access to Blucera.com.

Tekedia AI in Business Masterclass opens registrations.

Join Tekedia Capital Syndicate and co-invest in great global startups.

Register to become a better CEO or Director with Tekedia CEO & Director Program.

Ms. Byanyima emphasized that these abrupt cuts have already begun to devastate vulnerable communities, particularly women and girls. The situation evokes memories of the 1990s when HIV medication was scarcely available in poorer nations, leading to soaring infection rates and preventable deaths.

The Global HIV Crisis Worsens

The US has long been the largest single contributor to global HIV treatment and prevention. While Ms. Byanyima acknowledged America’s generosity, she stressed that the sudden withdrawal of funding has left a massive void with little time for mitigation. The UNAids chief acknowledged that it is reasonable for the US to seek to reduce its foreign aid commitments over time, but argued that an immediate halt is having disastrous consequences.

There is currently no indication that Washington will reconsider its decision, nor that traditional European donors will step in to fill the gap. As a result, UNAids is facing an unprecedented funding crisis that jeopardizes millions of lives.

Real Lives at Risk

Ms. Byanyima shared the case of Juliana, a young woman in Kenya living with HIV. Juliana worked for a US-funded program that helped new mothers access treatment to prevent their babies from contracting HIV. With the program now suspended, she has lost her job and fears losing access to her own medication while still breastfeeding her youngest child.

The World Health Organization (WHO) has warned that at least eight countries—Nigeria, Kenya, Lesotho, South Sudan, Burkina Faso, Mali, Haiti, and Ukraine—could soon run out of HIV drugs due to the US funding pause. WHO chief Tedros Adhanom Ghebreyesus cautioned that disruptions to HIV programs could erase two decades of progress in the fight against the disease.

In South Africa, the leading HIV/AIDS advocacy group, the Treatment Action Campaign (TAC), has voiced concerns that the country could return to an era when HIV patients struggled to access life-saving treatment. "We can't afford to die," said TAC Chair Sibongile Tshabalala. "We can't afford to go back to those years where we were suffering with access to services, especially for people living with HIV treatment."

A Proposed Solution: Lenacapavir and Economic Incentives

In an attempt to find common ground with the Trump administration, Ms. Byanyima has proposed a deal that could simultaneously support HIV patients and benefit the US economy. She suggested that UNAids could help market Lenacapavir, a new long-acting ARV injection developed by US pharmaceutical company Gilead. The drug, which is administered every six months, could help up to 10 million people, generating significant revenue and creating American jobs in the process.

Despite these potential benefits, the US government has yet to signal a willingness to reconsider its position.

Broader Consequences of US Funding Cuts

The impact of US foreign aid suspension extends beyond HIV programs. Other UN agencies are also facing severe financial shortfalls. The UN Refugee Agency has warned that it may have to eliminate 6,000 jobs, while UNICEF has stated that progress in reducing child mortality is at risk. Additionally, the World Food Programme has been forced to cut rations in regions facing famine.

The Need for Urgent Action

The US government's decision to pause foreign aid has sent shockwaves through the global health community. With millions of lives at risk and the possibility of an HIV resurgence, activists and global leaders are urging Washington to reconsider its stance before it is too late. UNAids and other humanitarian organizations continue to advocate for immediate funding restoration to prevent a dire humanitarian crisis.

As the world watches, the question remains: Will the US reverse course and reaffirm its commitment to global health, or will it allow decades of progress to unravel? The stakes could not be higher.

Uploaded files: